Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Physiology of Lipid Droplets and Triglyceride Storage
Aransas Citizens Against Drugs Coalition (ACADC)
Do High Dose B Vitamins Delay Age-Related Decay
MEDMYST: Dissemination Phase II
Cholesterol Absorption Rates in Normal Subjects Aged 17-80
Recently added grants:
Development of a single-dose rabies virus vaccine
Targeting virus-specific CAR T cells to lymphoid follicles to achieve durable HIV suppression
Regulation and Function of Mkp-1 During Sepsis.
Regulation of IgE responses by B cell receptor signaling
Molecular Pathophysiology of Thyroid Cell Growth
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67183-3-0-1
Application #
7574883
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ U of L Imperial Col of Sci/Technlgy/Med
$559,538
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Gibbs, Simon /
$649,798
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant